Moreover, we previously showed that curcumin can inhibit the IDO expression induced by IFN-γ and the EMT induced by TNF-α, suggesting curcumin could be a useful agent for antitumor therapy when combined with tumor vaccines. This evidence concerns the gene IDO1 and neoplasm.